Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Maintaining DNA health in stem cells is key to preventing aging and tissue breakdown.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

IL-1β inhibits human hair follicle growth.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Hair loss requires customized treatments based on its various causes and types.

Apple extract called procyanidin B-2 was found to greatly increase hair growth.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Androgens like testosterone increase colon muscle contractions by affecting calcium pathways.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Enzyme typing can reliably characterize human hair.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Erlotinib can cause hair loss as a side effect.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.